§ 4.100. Application of the general rating formula for diseases of the heart.
113 words·~1 min read·
/us/cfr/t38/s§ 4.100·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Whether or not cardiac hypertrophy or dilatation (documented by electrocardiogram, echocardiogram, or X-ray) is present and whether or not there is a need for continuous medication must be ascertained in all cases.
(b)Even if the requirement for a 10% (based on the need for continuous medication) or 30% (based on the presence of cardiac hypertrophy or dilatation) evaluation is met, METs testing is required in all cases except:
(1)When there is a medical contraindication.
(2)When a 100% evaluation can be assigned on another basis. (Authority: 38 U.S.C. 1155) \[71 FR 52460, Sept. 6, 2006, as amended at 86 FR 54093, Sept. 30, 2021; 86 FR 67654, Nov. 29, 2021\]
Connections2 cite this · traces to 1
Cited by 2 sections
Traces to 1 document
Citation graph
cites case law
Cites 1Cited by 2 across 1 source